TeleTx intervention for Alcoholism

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Michigan, Ann Arbor, MI
Alcoholism+4 More
TeleTx intervention - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this trial is to test new programs to see if they might help people manage their health and health behaviors related to alcohol use and well-being. The program sessions focus on getting to know what's important to the participants, reviewing or setting goals, and using different skills and behaviors to better manage health. The trial will help the study team learn about ways to deliver health information in a way that is useful and interesting. This research will take place remotely (e.g., Zoom, Facetime, Phone) and participants will be randomized to the Telehealth (TeleTx) group intervention or the Enhanced Usual Care (EUC) control group. Both groups will be asked to have follow-up visits up to 12 months from the baseline visit.

Eligible Conditions

  • Alcoholism
  • Substance Dependence
  • Substance Use Disorders (SUD)
  • Substance Use

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 4 Secondary · Reporting Duration: 12-months

12-months
Alcohol consumption days
Heavy drinking days
Total Alcohol Use Disorder Psychotherapy Treatment Attendance
3 months
Alcohol Use Disorder Treatment Engagement
Alcohol Use Disorder Treatment Initiation
Baseline to 12-months
Alcohol consequences
Drinking Risk Levels (Based on World Health Organization Cut-Offs)
World Health Organization Quality of Life Abbreviated (WHO-QOL-BREF)

Trial Safety

Trial Design

2 Treatment Groups

Enhanced Usual Care (EUC)
1 of 2
TeleTx intervention
1 of 2
Active Control
Experimental Treatment

300 Total Participants · 2 Treatment Groups

Primary Treatment: TeleTx intervention · No Placebo Group · N/A

TeleTx intervention
Behavioral
Experimental Group · 1 Intervention: TeleTx intervention · Intervention Types: Behavioral
Enhanced Usual Care (EUC)
Behavioral
ActiveComparator Group · 1 Intervention: Enhanced Usual Care (EUC) · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 12-months
Closest Location: University of Michigan · Ann Arbor, MI
Photo of university of michigan comprehensive cancer center 1Photo of university of michigan comprehensive cancer center 2Photo of university of michigan comprehensive cancer center 3
2022First Recorded Clinical Trial
1 TrialsResearching Alcoholism
1005 CompletedClinical Trials

Who is running the clinical trial?

University of MichiganLead Sponsor
1,597 Previous Clinical Trials
6,328,757 Total Patients Enrolled
7 Trials studying Alcoholism
5,965 Patients Enrolled for Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
692 Previous Clinical Trials
1,167,809 Total Patients Enrolled
361 Trials studying Alcoholism
971,482 Patients Enrolled for Alcoholism
Erin Bonar, PhDPrincipal InvestigatorUniversity of Michigan
1 Previous Clinical Trials
1,280 Total Patients Enrolled
Allison Lin, MDPrincipal InvestigatorUniversity of Michigan
1 Previous Clinical Trials
50 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have had an average of 3 or more drinking days per week for the past 30 days.
You have regular access to a device with video capabilities or a phone to use for study related calls.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.